IN2014CN04470A - - Google Patents
Download PDFInfo
- Publication number
- IN2014CN04470A IN2014CN04470A IN4470CHN2014A IN2014CN04470A IN 2014CN04470 A IN2014CN04470 A IN 2014CN04470A IN 4470CHN2014 A IN4470CHN2014 A IN 4470CHN2014A IN 2014CN04470 A IN2014CN04470 A IN 2014CN04470A
- Authority
- IN
- India
- Prior art keywords
- ketoreductase polypeptides
- preparation
- present disclosure
- making
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/001—Amines; Imines
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/02—Amides, e.g. chloramphenicol or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
- C12P41/002—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by oxidation/reduction reactions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
- C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
- C12Y101/01184—Carbonyl reductase (NADPH) (1.1.1.184)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161561665P | 2011-11-18 | 2011-11-18 | |
| PCT/US2012/065046 WO2013074650A1 (en) | 2011-11-18 | 2012-11-14 | Biocatalysts for the preparation of hydroxy substituted carbamates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014CN04470A true IN2014CN04470A (hu) | 2015-09-04 |
Family
ID=47295185
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN4470CHN2014 IN2014CN04470A (hu) | 2011-11-18 | 2012-11-14 |
Country Status (8)
| Country | Link |
|---|---|
| US (8) | US9139819B2 (hu) |
| EP (1) | EP2780448B1 (hu) |
| CN (2) | CN104053771B (hu) |
| HU (1) | HUE046089T2 (hu) |
| IL (1) | IL232621B (hu) |
| IN (1) | IN2014CN04470A (hu) |
| SG (1) | SG11201402401TA (hu) |
| WO (1) | WO2013074650A1 (hu) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010536385A (ja) | 2007-08-24 | 2010-12-02 | コデクシス， インコーポレイテッド | （ｒ）−３−ヒドロキシチオランの立体選択的生成のための改善されたケトレダクターゼポリペプチド |
| ES2584427T3 (es) | 2011-10-27 | 2016-09-27 | Merck Sharp & Dohme Corp. | Proceso para la preparación de agonistas beta 3 y productos intermedios |
| WO2013062881A1 (en) | 2011-10-27 | 2013-05-02 | Merck Sharp & Dohme Corp. | Process for making beta 3 agonists and intermediates |
| US9139819B2 (en) | 2011-11-18 | 2015-09-22 | Codexis, Inc. | Biocatalysts for the preparation of hydroxy substituted carbamates |
| EP2970927A4 (en) * | 2013-03-15 | 2016-10-12 | Merck Sharp & Dohme | IMMOBILIZED KETOREDUCTASES AND METHODS OF MAKING AND USING IMMOBILIZED KETOREDUCTASE |
| EP2968269B1 (en) | 2013-03-15 | 2019-07-10 | Merck Sharp & Dohme Corp. | Process for preparing beta 3 agonists and intermediates |
| ES2830725T3 (es) | 2015-02-10 | 2021-06-04 | Codexis Inc | Polipéptidos cetoreductasa para la síntesis de compuestos quirales |
| CN106011095B (zh) * | 2016-07-27 | 2021-02-26 | 苏州汉酶生物技术有限公司 | 工程化酮还原酶多肽及使用其制备依替米贝中间体的方法 |
| CN109943543B (zh) * | 2019-03-28 | 2020-12-11 | 上海健康医学院 | 醇脱氢酶突变体及其制备方法和应用 |
| CN114410599B (zh) * | 2022-01-29 | 2023-08-18 | 浙江工业大学 | 羰基还原酶突变体及其制备瑞舒伐他汀手性中间体的应用 |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5538867A (en) | 1988-09-13 | 1996-07-23 | Elf Aquitaine | Process for the electrochemical regeneration of pyridine cofactors |
| JP3155107B2 (ja) | 1993-01-12 | 2001-04-09 | ダイセル化学工業株式会社 | 光学活性４−ハロ−３−ヒドロキシ酪酸エステルの製造方法 |
| US5605793A (en) | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
| US6117679A (en) | 1994-02-17 | 2000-09-12 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| US5837458A (en) | 1994-02-17 | 1998-11-17 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
| US6335160B1 (en) | 1995-02-17 | 2002-01-01 | Maxygen, Inc. | Methods and compositions for polypeptide engineering |
| KR100477070B1 (ko) | 1994-03-25 | 2006-04-21 | 이소테크니카 인코포레이티드 | 중수소화작용에의한의약품의효능강화법 |
| JPH08336393A (ja) | 1995-04-13 | 1996-12-24 | Mitsubishi Chem Corp | 光学活性なγ−置換−β−ヒドロキシ酪酸エステルの製造法 |
| FI104465B (fi) | 1995-06-14 | 2000-02-15 | Valio Oy | Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö |
| US5891685A (en) | 1996-06-03 | 1999-04-06 | Mitsubishi Chemical Corporation | Method for producing ester of (S)-γ-halogenated-β-hydroxybutyric acid |
| US6342507B1 (en) | 1997-09-05 | 2002-01-29 | Isotechnika, Inc. | Deuterated rapamycin compounds, method and uses thereof |
| DK0991660T3 (da) | 1997-10-08 | 2006-02-13 | Isotechnika Inc | Deuterede og udeuterede cyclosporinanaloger og deres anvendelse som immunmodulerende midler |
| EP1036198B1 (en) | 1997-12-08 | 2012-09-26 | California Institute Of Technology | Method for creating polynucleotide and polypeptide sequences |
| US6495023B1 (en) | 1998-07-09 | 2002-12-17 | Michigan State University | Electrochemical methods for generation of a biological proton motive force and pyridine nucleotide cofactor regeneration |
| DE19857302C2 (de) | 1998-12-14 | 2000-10-26 | Forschungszentrum Juelich Gmbh | Verfahren zur enantioselektiven Reduktion von 3,5-Dioxocarbonsäuren, deren Salze und Ester |
| JP4221100B2 (ja) | 1999-01-13 | 2009-02-12 | エルピーダメモリ株式会社 | 半導体装置 |
| US6376246B1 (en) | 1999-02-05 | 2002-04-23 | Maxygen, Inc. | Oligonucleotide mediated nucleic acid recombination |
| EP1621613B1 (en) | 1999-03-11 | 2009-04-22 | Eastman Chemical Company | Enzymatic reductions with dihydrogen via metal catalyzed cofactor regeneration |
| CZ20012792A3 (cs) | 1999-12-03 | 2002-03-13 | Kaneka Corporation | Polypeptid, polynukleotid kódující polypeptid, expresní vektor, transformant a způsob přípravy |
| EP1272967A2 (en) | 2000-03-30 | 2003-01-08 | Maxygen, Inc. | In silico cross-over site selection |
| BR0208265A (pt) | 2001-03-22 | 2004-03-02 | Bristol Myers Squibb Co | Redução estereosseletiva de acetofenona substituìda |
| US20050084907A1 (en) | 2002-03-01 | 2005-04-21 | Maxygen, Inc. | Methods, systems, and software for identifying functional biomolecules |
| EP1654354A1 (en) | 2003-08-11 | 2006-05-10 | Codexis, Inc. | Improved ketoreductase polypeptides and related polynucleotides |
| MXPA06001719A (es) | 2003-08-11 | 2006-05-19 | Codexis Inc | Polipeptidos de glucosa deshidrogenasa mejorados, y polinucleotidos relacionados. |
| BRPI0413501A (pt) | 2003-08-11 | 2006-10-10 | Codexis Inc | polipetìdeo, polinucleotìdeo isolado ou recombinante, vetor de expressão, célula hospedeira, e, método de preparar um polipetìdeo de hhdh |
| JP2007502111A (ja) | 2003-08-11 | 2007-02-08 | コデクシス， インコーポレイテッド | ４−置換３−ヒドロキシ酪酸誘導体およびビシナルなシアノ，ヒドロキシ置換カルボン酸エステルの生成のための酵素的プロセス |
| EP1712633A1 (en) | 2003-12-02 | 2006-10-18 | Mercian Corporation | Process for producing optically active tetrahydrothiophene derivative and method of crystallizing optically active tetrahydrothiophen-3-ol |
| US7705036B2 (en) | 2004-04-01 | 2010-04-27 | Cardiome Pharma Corp. | Deuterated aminocyclohexyl ether compounds and processes for preparing same |
| WO2006130657A2 (en) | 2005-05-31 | 2006-12-07 | Bristol-Myers Squibb Company | Stereoselective reduction process for the preparation of pyrrolotriazine compounds |
| JP2010517574A (ja) | 2007-02-08 | 2010-05-27 | コデクシス， インコーポレイテッド | ケトレダクターゼおよびその使用 |
| US20090118130A1 (en) | 2007-02-12 | 2009-05-07 | Codexis, Inc. | Structure-activity relationships |
| JP2010536385A (ja) | 2007-08-24 | 2010-12-02 | コデクシス， インコーポレイテッド | （ｒ）−３−ヒドロキシチオランの立体選択的生成のための改善されたケトレダクターゼポリペプチド |
| JP5973131B2 (ja) | 2007-09-13 | 2016-08-23 | コデクシス， インコーポレイテッド | アセトフェノンの還元のためのケトレダクターゼポリペプチド |
| KR20100061571A (ko) | 2007-09-28 | 2010-06-07 | 코덱시스, 인코포레이티드 | 케토리덕타제 폴리펩티드 및 이의 용도 |
| WO2009046153A1 (en) | 2007-10-01 | 2009-04-09 | Codexis, Inc. | Ketoreductase polypeptides for the production of azetidinone |
| PE20091825A1 (es) | 2008-04-04 | 2009-12-04 | Merck & Co Inc | Hidroximetil pirrolidinas como agonistas del receptor adrenergico beta 3 |
| US20090312196A1 (en) | 2008-06-13 | 2009-12-17 | Codexis, Inc. | Method of synthesizing polynucleotide variants |
| US8288141B2 (en) | 2008-08-27 | 2012-10-16 | Codexis, Inc. | Ketoreductase polypeptides for the production of 3-aryl-3-hydroxypropanamine from a 3-aryl-3-ketopropanamine |
| SI2329013T1 (sl) | 2008-08-27 | 2016-03-31 | Codexis, Inc. | Polipeptidi ketoreduktaze za proizvodnjo 3-aril-3-hidroksipropanamina iz 3-aril-3-ketopropanamina |
| WO2010027710A2 (en) | 2008-08-27 | 2010-03-11 | Codexis, Inc. | Ketoreductase polypeptides and uses thereof |
| US8273554B2 (en) | 2008-08-29 | 2012-09-25 | Codexis, Inc. | Ketoreductase polypeptides for the stereoselective production of (4S)-3-[(5S)-5-(4-fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidin-2-one |
| EP2467473B1 (en) | 2009-08-19 | 2016-03-23 | Codexis, Inc. | Ketoreductase polypeptides for the preparation of phenylephrine |
| EP2566497B1 (en) | 2010-05-04 | 2015-07-29 | Codexis, Inc. | Biocatalysts for ezetimibe synthesis |
| US9139819B2 (en) | 2011-11-18 | 2015-09-22 | Codexis, Inc. | Biocatalysts for the preparation of hydroxy substituted carbamates |
-
2012
- 2012-11-14 US US14/357,964 patent/US9139819B2/en active Active
- 2012-11-14 CN CN201280067329.9A patent/CN104053771B/zh active Active
- 2012-11-14 WO PCT/US2012/065046 patent/WO2013074650A1/en active Application Filing
- 2012-11-14 EP EP12795954.2A patent/EP2780448B1/en active Active
- 2012-11-14 SG SG11201402401TA patent/SG11201402401TA/en unknown
- 2012-11-14 CN CN201610911937.3A patent/CN106479990B/zh active Active
- 2012-11-14 IN IN4470CHN2014 patent/IN2014CN04470A/en unknown
- 2012-11-14 HU HUE12795954A patent/HUE046089T2/hu unknown
-
2014
- 2014-05-14 IL IL23262114A patent/IL232621B/en active IP Right Grant
-
2015
- 2015-08-13 US US14/825,688 patent/US9422531B2/en active Active
-
2016
- 2016-07-15 US US15/211,990 patent/US9803178B2/en active Active
-
2017
- 2017-09-21 US US15/711,119 patent/US10100287B2/en active Active
-
2018
- 2018-09-10 US US16/126,044 patent/US10253303B2/en active Active
-
2019
- 2019-02-25 US US16/284,235 patent/US10851351B2/en active Active
-
2020
- 2020-10-29 US US17/084,405 patent/US11713451B2/en active Active
-
2023
- 2023-06-12 US US18/333,393 patent/US20240018489A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP2780448A1 (en) | 2014-09-24 |
| IL232621A0 (en) | 2014-06-30 |
| CN104053771A (zh) | 2014-09-17 |
| US20180371427A1 (en) | 2018-12-27 |
| HUE046089T2 (hu) | 2020-01-28 |
| US10851351B2 (en) | 2020-12-01 |
| US9139819B2 (en) | 2015-09-22 |
| EP2780448B1 (en) | 2019-09-11 |
| CN106479990B (zh) | 2020-09-18 |
| US9422531B2 (en) | 2016-08-23 |
| IL232621B (en) | 2019-10-31 |
| WO2013074650A1 (en) | 2013-05-23 |
| US9803178B2 (en) | 2017-10-31 |
| US10100287B2 (en) | 2018-10-16 |
| US20240018489A1 (en) | 2024-01-18 |
| US10253303B2 (en) | 2019-04-09 |
| US20180010100A1 (en) | 2018-01-11 |
| US20190177702A1 (en) | 2019-06-13 |
| CN104053771B (zh) | 2016-11-09 |
| US20160319247A1 (en) | 2016-11-03 |
| CN106479990A (zh) | 2017-03-08 |
| US20210071151A1 (en) | 2021-03-11 |
| SG11201402401TA (en) | 2014-06-27 |
| US20150344850A1 (en) | 2015-12-03 |
| US11713451B2 (en) | 2023-08-01 |
| US20140322769A1 (en) | 2014-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014CN04470A (hu) | ||
| ZA201502433B (en) | Methods of host cell modification | |
| IL231171A0 (en) | RNA-derived t cells for cancer treatment | |
| AP3964A (en) | Methods of processing lignocellulosic biomass | |
| IN2014CN04586A (hu) | ||
| MX2013007853A (es) | Polipeptidos que tienen actividad de celobiohidrolasa y polinucleotidos que codifican los mismos. | |
| MX337919B (es) | Polipeptidos que tienen actividad de celobiohidrolasa y polinucleotidos que codifican los mismos. | |
| PL3070170T3 (pl) | Fermentacja CO<sub>2</sub> z zastosowaniem potencjału elektrycznego | |
| MX337913B (es) | Polipeptidos que tienen actividad celobiohidrolasa y polinucleotidos que codifican los mismos. | |
| MX355356B (es) | Variantes de alfa-amilasa y polinucleotidos que codifican las mismas. | |
| SG10201510009YA (en) | Methods of metabolic targeting cancer cells using chemo- and immunotherapy for treating cancer | |
| MX354704B (es) | Variantes de alfa-amilasa y polinucleotidos que codifican las mismas. | |
| ZA201504408B (en) | Solution formulations of engineered anti-il-23p19 antibodies | |
| EP2912166A4 (en) | METHOD FOR THE PRODUCTION OF PLURIPOTENTIAL STEM CELLS FROM CHONDROCYTES | |
| SG11201406115VA (en) | Culture medium for proliferating stem cell, which contains sulfated compound | |
| MX2014001594A (es) | Polipeptidos que tienen actividad de celulasa y polinucleotidos que los codifican. | |
| EP2831234A4 (en) | COMPOSITIONS, METHODS AND GENES OF PLANTS FOR BETTER PRODUCTION OF FERMENTABLE SUGARS FOR BIOFUELS PRODUCTION | |
| ZA201403104B (en) | Process for the preparation of higher alcohols | |
| WO2013011062A3 (en) | Antagonistic antibodies against oscar | |
| MY166897A (en) | Stable compositions and methods for preparing the same | |
| IL229242B (en) | Allogeneic cell vaccine for cancer | |
| AU2012905250A0 (en) | Uses of Bacopa monnieri extract | |
| GB201219906D0 (en) | Matrix binders, uses & methods of manufacture | |
| AU2011902709A0 (en) | Process for the extraction of galactooligosaccharide | |
| WO2012135696A3 (en) | Methods and compositions for the diagnosis, classification, and treatment of cancer |